Trastuzumab Deruxtecan for HER2-Low Metastatic Breast Cancer: Practical Considerations for Medical Oncologists and Pathologists in Australia. - Redfern A; Lim E; Lakhani S; Pathmanathan N; Selva-Nayagam S; McCarthy N; Yeo B; Dessauvagie B; Farshid G (Asia-Pacific journal of clinical oncology, 2026)